{"pageContent": "Background: A new 5-tiered grading grouping system has recently been endorsed for reporting of prostate cancer (PCa) grade to better reflect escalating risk of progression and cancer death. While several validations of the new grade groupings have been undertaken, most have involved centralised pathological review by specialist urological pathologists.", "metaData": {"source": "Androgen receptor: role and novel therapeutic prospects in prostate cancer\nhttps://pubmed.ncbi.nlm.nih.gov/18759700/"}}